• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Dr Oz to face Senate grilling on Capitol Hill in bid to run Centers for Medicare and Medicaid

by March 14, 2025
written by March 14, 2025

Dr. Mehmet Oz, President Donald Trump’s pick to lead the Centers for Medicare and Medicaid, will face questions in front of the Senate Committee on Finance Friday morning. 

Following the hearing, the committee will schedule a vote to send Oz’s nomination to the full Senate, where approval is likely, considering the Republican majority.

If confirmed, Oz would be in charge of nearly $1.5 trillion in federal healthcare spending. Medicare, a federal healthcare program for seniors aged 65 and up, currently provides coverage for about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, which assists people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov.

A former heart surgeon who saw his fame rise through his appearances on daytime TV and 13 seasons of ‘The Dr Oz Show,’ Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He ultimately lost to John Fetterman, then the state’s lieutenant governor. Oz graduated from Harvard and received medical and business degrees from the University of Pennsylvania. 

Oz is expected to be grilled by Democrats during the hearing over his financial ties to a myriad of healthcare-related companies, several of which pose potential conflicts of interest for the potential CMS director.

Oz has committed to divesting many of his financial interests that pose the most obvious risk of impropriety, such as his hundreds of thousands of dollars in stock in United Health Group, a major private health insurer. He also said that if he were confirmed, he would forfeit the nearly $25 million in stock options he obtained as an advisor to a company selling health and beauty supplements.

As the administrator of CMS, Oz would make decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates at which healthcare providers get paid for their services. 

On Thursday, Trump’s pick to lead the NIH and FDA, Dr. Jay Bhattacharya and Dr. Marty Makary, respectively, were approved in committee and will now face impending votes by the full Senate.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Dollar General CEO warns consumers are cash-strapped and says 2025 won’t be better
next post
Senate to take up Trump spending bill as clock ticks down to government shutdown

related articles

James Comer praises Kash Patel for ‘holding deep...

August 22, 2025

Trump DOJ to begin handing over Epstein files...

August 22, 2025

TikTok isn’t enough to stop Gen Z from...

August 22, 2025

Trump administration wins Supreme Court fight to slash...

August 22, 2025

Zelenskyy seeks ‘strong reaction’ from US if Putin...

August 22, 2025

Pentagon unveils new medal for troops deployed in...

August 21, 2025

Federal judge rules Trump appointee Alina Habba is...

August 21, 2025

‘Maine’s Mamdani’: Maine GOP chief issues warning about...

August 21, 2025

‘There are 50 swamps’: State Freedom Caucus Network...

August 21, 2025

Trump-aligned legal group probes Biden-era organ transplant program...

August 21, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Doctors react after Biden’s live address to the nation: A concerning ‘lack of emotion’

    July 25, 2024
  • DAs may try to charge Jan. 6 participants granted clemency by Trump with new crimes on state, local levels

    January 27, 2025
  • Netflix says its ad tier now has 94 million monthly active users

    May 15, 2025
  • Election Day in Wisconsin, Florida: What to watch as conservatives face a statewide electoral test

    April 1, 2025
  • Fact-checking firm staffed by CNN alums takes Meta axing hard: ‘Surprised and disappointed’

    January 8, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (5,786)
  • Investing (634)
  • Stock (894)

Latest Posts

  • ‘JOE, YOU’RE FIRED’: President Trump revokes Biden’s security clearance, intel briefings

    February 8, 2025
  • Dems hitting Vance with debunked vulgar claim ‘undermine’ their anti-Trump credibility, strategist says

    August 12, 2024
  • ‘Our position is clear:’ Zelenskyy and EU dismiss ceding Ukrainian land to Russia

    August 17, 2025

Recent Posts

  • ‘$1 billion disaster’: Here’s what FEC filings show about Harris campaign’s 3 month spending spree

    November 12, 2024
  • S&P 500 and Nasdaq: New Targets and Prices for Wednesday

    October 9, 2024
  • White House silent on whether transcript of Biden’s ‘garbage’ comments was approved by stenographers

    October 31, 2024

Editor’s Pick

  • Liz Cheney lambastes Trump over Russia/Ukraine, branding him ‘the antithesis’ of all ‘Reagan stood for’

    February 20, 2025
  • Hegseth orders Pentagon to launch comprehensive review into ‘catastrophic’ 2021 Afghanistan withdrawal

    May 20, 2025
  • Jay Bhattacharya, prominent physician and economist, nominated by Trump for NIH director

    November 27, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock